October 05, 2015.
EMD Serono (Rockland, MA) has awarded its 2015 Grant for Growth Innovation (GGI) to two recipients. The awards were handed over during the official award ceremony at the 54th European Society for Paediatric Endocrinology (ESPE) Meeting in Barcelona, Spain, on Saturday.
The awards went to Professor David Dunger, MD, University of Cambridge, Cambridge, UK for the "Effect of insulin sensitisation on Insulin-Like Growth Factor-I levels in response to Growth Hormone treatment in children born small for gestational age", and to Edward List, PhD, Edison Biotechnology Institute, Ohio University, Athens, OH, for "Experimental use of an alternative form of growth hormone."
EMD Serono initiated the GGI program to support the advancement of understanding of the field of growth. A total grant of up to €400,000 ($448, 340) per year is divided between up to three research proposals.
For further information about the GGI and how to apply for next year's grants, visit http://www.grantforgrowthinnovation.org
Is Artificial Intelligence a ‘Product’? Products Liability Implications for AI-Based Products
April 10th 2025As the physical products we use evolve to become increasingly complex, traditional products liability frameworks may not always fit to provide remedies for harm that can result from using novel product types.